C1q-like 1 is frequently up-regulated in lung adenocarcinoma and contributes to the proliferation and invasion of tumor cells

References

• Al-Lawati JA, Al-Bahrani BJ, Al-Lawati NA, Al-Zakwani I. Epidemiology of lung cancer in Oman: 20-year trends and tumor characteristics. Oman Med J. 2019;34(5):397–403.
   PubMedGoogle Scholar
• Jordan EJ, Kim HR, Arcila ME, Barron D, Chakravarty D, Gao J, Chang MT, Ni A, Kundra R, Jonsson P, et al. Prospective comprehensive molecular characterization of lung adenocarcinomas for efficient patient matching to approved and emerging therapies. Cancer Discov. 2017;7(6):596–609.
   PubMed Web of Science ®Google Scholar
• Mao Y, Yang D, He J, Krasna MJ. Epidemiology of lung cancer. Surg Oncol Clin N Am. 2016;25(3):439–45.
   PubMed Web of Science ®Google Scholar
• Zhuang H, Shi S, Guo Y, Wang Z. Increase of secondary mutations may be a drug-resistance mechanism for lung adenocarcinoma after radiation therapy combined with tyrosine kinase inhibitor. J Cancer. 2019;10(22):5371–6.
   PubMed Web of Science ®Google Scholar
• Maia R, Neves I, Morais A, Queiroga H. Venous and lung thromboembolism in the context of lung cancer: clinical manifestations, risk factors and prognosis. Acta Med Port. 2019;32(10):647–53.
   PubMed Web of Science ®Google Scholar
• Sie CPS. Maas Conserved recoding RNA editing of vertebrate C1q-related factor C1QL1. FEBS Lett. 2009;583(7):1171–4.
   PubMed Web of Science ®Google Scholar
• Berube NG, Swanson XH, Bertram MJ, Kittle JD, Didenko V, Baskin DS, Smith JR, Pereira-Smith OM. Cloning and characterization of CRF, a novel C1q-related factor, expressed in areas of the brain involved in motor function. Brain Res Mol Brain Res. 1999;63(2):233–40.
   PubMedGoogle Scholar
• Yuzaki M. The C1q complement family of synaptic organizers: not just complementary. Curr Opin Neurobiol. 2017;45:9–15.
   PubMed Web of Science ®Google Scholar
• Ressl S, Vu BK, Vivona S, Martinelli DC, Sudhof TC, Brunger AT. Structures of C1q-like proteins reveal unique features among the C1q/TNF superfamily. Structure. 2015;23(4):688–99.
   PubMed Web of Science ®Google Scholar
• Sałkowska A, Karaś K, Karwaciak I, Walczak-Drzewiecka A, Krawczyk M, Sobalska-Kwapis M, Dastych J, Ratajewski M. Identification of novel molecular markers of human Th17 cells. Cells. 2020;9(7):1611.
   Web of Science ®Google Scholar
• Celestino R, Nome T, Pestana A, Hoff AM, Goncalves AP, Pereira L, Cavadas B, Eloy C, Bjoro T, Sobrinho-Simoes M, et al. CRABP1, C1QL1 and LCN2 are biomarkers of differentiated thyroid carcinoma, and predict extrathyroidal extension. BMC Cancer. 2018;18(1):68.
   PubMedGoogle Scholar
• Qiu X, Feng JR, Wang F, Chen PF, Chen XX, Zhou R, Chang Y, Liu J, Zhao Q. Profiles of differentially expressed genes and overexpression of NEBL indicates a positive prognosis in patients with colorectal cancer. Mol Med Rep. 2018;17(2):3028–34.
   PubMed Web of Science ®Google Scholar
• Song J, Wang W, Wang Y, Qin Y, Wang Y, Zhou J, Wang X, Zhang Y, Wang Q. Epithelial–mesenchymal transition markers screened in a cell-based model and validated in lung adenocarcinoma. BMC Cancer. 2019;19(1):680.
   PubMedGoogle Scholar
• Santamaria PG, Moreno-Bueno G, Portillo F, Cano A. EMT: present and future in clinical oncology. Mol Oncol. 2017;11(7):718–38.
   PubMed Web of Science ®Google Scholar
• Bolliger MF, Martinelli DC, Sudhof TC. The cell-adhesion G protein-coupled receptor BAI3 is a high-affinity receptor for C1q-like proteins. Proc Natl Acad Sci USA. 2011;108(6):2534–9.
   PubMed Web of Science ®Google Scholar
• Li AD, Tong L, Xu N, Ye Y, Nie PY, Wang ZY, Ji LL. miR-124 regulates cerebromicrovascular function in APP/PS1 transgenic mice via C1ql3. Brain Res Bull. 2019;153:214–22.
   PubMed Web of Science ®Google Scholar
• Ramjiawan RR, Griffioen AW, Duda DG. Anti-angiogenesis for cancer revisited: is there a role for combinations with immunotherapy? Angiogenesis. 2017; 20(2):185–204.
   PubMed Web of Science ®Google Scholar
• Traylor M, Zhang CR, Adib-Samii P, Devan WJ, Parsons OE, Lanfranconi S, Gregory S, Cloonan L, Falcone GJ, Radmanesh F, et al. C International stroke genetics. Genome-wide meta-analysis of cerebral white matter hyperintensities in patients with stroke. Neurology. 2016;86(2):146–53.
   PubMedGoogle Scholar
• Bulla R, Tripodo C, Rami D, Ling GS, Agostinis C, Guarnotta C, Zorzet S, Durigutto P, Botto M, Tedesco F. C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation. Nat Commun. 2016;7:10346.
   PubMed Web of Science ®Google Scholar
• Li Y, Wright GL, Peterson JM. C1q/TNF-related protein 3 (CTRP3) function and regulation. Compr Physiol. 2017;7(3):863–78.
   PubMed Web of Science ®Google Scholar
• Eramo A, Haas TL, De Maria R. Lung cancer stem cells: tools and targets to fight lung cancer. Oncogene. 2010;29(33):4625–35.
   PubMed Web of Science ®Google Scholar
• Gupta GPJ. Massague Cancer metastasis: building a framework. Cell. 2006;127(4):679–95.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Dai J, Chen T, Dada LA, Zhang X, Zhang W, DeCamp MM, Winn RA, Sznajder JI, Zhou G. Downregulation of PKCζ/Pard3/Pard6b is responsible for lung adenocarcinoma cell EMT and invasion. Cell Signal. 2017;38:49–59.
   PubMed Web of Science ®Google Scholar
• Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer. 2007;7(6):415–28.
   PubMed Web of Science ®Google Scholar
• Xu M, Zhang Y, Cui M, Wang X, Lin Z. Mortalin contributes to colorectal cancer by promoting proliferation and epithelial–mesenchymal transition. IUBMB Life. 2020;72(4):771–81.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Zhu B, Qian J, Wang K, Zhou J. miR-942 promotes proliferation and metastasis of hepatocellular carcinoma cells by inhibiting RRM2B. Onco Targets Ther. 2019;12:8367–78.
   PubMedGoogle Scholar
• Huang Q, Han J, Fan J, Duan L, Guo M, Lv Z, Hu G, Chen L, Wu F, Tao X, Jin Y , et al. IL-17 induces EMT via Stat3 in lung adenocarcinoma. Am J Cancer Res. 2016;6(2):440–51.
   PubMed Web of Science ®Google Scholar
• Jia Y, Duan Y, Liu T, Wang X, Lv W, Wang M, Wang J, Liu L. LncRNA TTN-AS1 promotes migration, invasion, and epithelial mesenchymal transition of lung adenocarcinoma via sponging miR-142-5p to regulate CDK5. Cell Death Dis. 2019; 10(8):573.
   PubMed Web of Science ®Google Scholar
• Liu F, Tan A, Yang R, Xue Y, Zhang M, Chen L, Xiao L, Yang X, Yu Y. C1ql1/Ctrp14 and C1ql4/Ctrp11 promote angiogenesis of endothelial cells through activation of ERK1/2 signal pathway. Mol Cell Biochem. 2017;424(1-2):57–67. doi:https://doi.org/10.1007/s11010-016-2842-7.
   PubMed Web of Science ®Google Scholar
• Geun-Hyoung H, Park JS, Breuer EKY. TACC3 promotes epithelial–mesenchymal transition (EMT) through the activation of PI3K/Akt and ERK signaling pathways. Cancer Lett. 2013;332(1):63–73.
   PubMed Web of Science ®Google Scholar
• Conacci-Sorrell M, Simcha I, Ben-Yedidia T, Blechman J, Savagner P. Autoregulation of E-cadherin expression by cadherin–cadherin interactions: the roles of beta-catenin signaling, slug, and MAPK. J Cell Biol. 2003; 163(4):847–57.
   PubMed Web of Science ®Google Scholar
• Buonato JM, Lazzara MJ. ERK1/2 blockade prevents epithelial–mesenchymal transition in lung cancer cells and promotes their sensitivity to EGFR inhibition. Cancer Res. 2014;74(1):309–19.
   PubMed Web of Science ®Google Scholar
• Sigoillot SM, Iyer K, Binda F, González-Calvo I, Talleur M, Vodjdani G, Isope P, Selimi F. The secreted protein C1QL1 and its receptor BAI3 control the synaptic connectivity of excitatory inputs converging on cerebellar Purkinje cells. Cell Rep. 2015;10(5):820–32.
   PubMed Web of Science ®Google Scholar